Last update 01 Nov 2024

IGF-1R x PYK2 x ALK x FAK

Basic Info

Related Targets
IGF-1RPYK2ALK[+1]

Related

1
Drugs associated with IGF-1R x PYK2 x ALK x FAK
Conteltinib
Target
ALK x FAK x IGF-1R x PYK2
Mechanism
ALK inhibitors [+3]
Active Org.
Zhejiang UniversityZhejiang University [+3]
Originator Org.
Centaurus Biopharma Co LtdCentaurus Biopharma Co Ltd
Active Indication
ALK positive Non-Small Cell Lung Cancer [+2]
Inactive Indication-
Drug Highest PhaseNDA/BLA
First Approval Ctry. / Loc.-
First Approval Date20 Jan 1800
11
Clinical Trials associated with IGF-1R x PYK2 x ALK x FAK
CTR20222060 / RecruitingPhase 2
评价CT-707联合特瑞普利单抗注射液和吉西他滨在晚期胰腺癌患者中的安全性、耐受性、药代动力学和有效性的Ib/II 期研究
[Translation] A Phase Ib/II study to evaluate the safety, tolerability, pharmacokinetics, and efficacy of CT-707 combined with toripalimab injection and gemcitabine in patients with advanced pancreatic cancer
100 Clinical Results associated with IGF-1R x PYK2 x ALK x FAK
Login to view more data
100 Translational Medicine associated with IGF-1R x PYK2 x ALK x FAK
Login to view more data
0 Patents (Medical) associated with IGF-1R x PYK2 x ALK x FAK
Login to view more data

Analysis

Perform a panoramic analysis of this field.
login
or
view full example data
Perform a panoramic analysis of this field.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free